News

News Release – EU Clinical Study

News Release – EU Clinical Study

Protembis announces completion of 20 cases in European CE mark study with the ProtEmbo® Cerebral Protection System Enrollment with advanced...
Read More
News Release – Special Report First-in-Human 2nd Generation
News Release – Series A Financing

News Release – Series A Financing

Aachen-based Startup Company Protembis Successfully Closes $ 10 Million Series A Financing Protembis Develops a Novel Catheter-Based Filter System to...
Read More
News Release – ISO 13485:2016

News Release – ISO 13485:2016

Protembis Achieves ISO 13485:2016 Quality Management System Certification Protembis GmbH announced today its successful certification in compliance with ISO 13485:2016....
Read More
News Release – First in Human

News Release – First in Human

Protembis announces successful first-in-human use of its ProtEmbo®Cerebral Protection System in European trial Protembis GmbH, a privately held medical device...
Read More
News Release – German Accelerator Life Sciences

News Release – German Accelerator Life Sciences

Protembis Initiates Collaboration with German Accelerator Life Sciences for Planned U.S. Expansion Company Set to Initiate European First-in-Human Trial with...
Read More
News Release – Seed Financing

News Release – Seed Financing

Medical device company Protembis GmbH has closed its seed financing round Led by Innovationsstarter Fonds Hamburg GmbH, Geratherm Medical AG...
Read More
News Release – KMU innovativ: Medizintechnik

News Release – KMU innovativ: Medizintechnik

Medical device company Protembis GmbH wins state subsidy programme “KMU-innovativ: Medizintechnik” Medical device company Protembis GmbH wins state subsidy programme...
Read More